FDA Should Include More Factors in Risk Calculations, Groups Comment

The GMP Letter
A A
FDA guidance on risk-benefit decisionmaking in premarket device approvals should include multiple factors for determining whether a device presents low risk, the Medical Imaging & Technology Alliance said in comments on the final guidance.

To View This Article:

Login

Subscribe To The GMP Letter